Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells

Nanocarriers have the potential to improve the therapeutic index of currently available drugs by improving their efficacy and achieving therapeutic steady-state levels over an extended period. The association of maghemite–rhodium citrate (MRC) nanoparticles (NPs) has the potential to increase specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaves, Natalia L, Estrela-Lopis, Irina, Böttner, Julia, Lopes, Cláudio AP, Guido, Bruna C, de Sousa, Aparecido R, Báo, Sônia N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546771/
https://www.ncbi.nlm.nih.gov/pubmed/28814867
http://dx.doi.org/10.2147/IJN.S141582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546771/
https://www.ncbi.nlm.nih.gov/pubmed/28814867
http://dx.doi.org/10.2147/IJN.S141582

Ejemplares similares